CervoMed announced plans to initiate a Phase III clinical trial in the second half of 2026 to evaluate the efficacy and safety of its candidate drug Neflamapimod in patients with dementia with Lewy bodies (DLB).
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This move marks an important step in the drug's development process, with the company actively advancing its treatment pipeline for neurodegenerative diseases.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Scholar Rock Shares Fall After Barclays Downgrade
MT newswire•2026/09/15 18:59
August US Retail Sales Expected to Rise by 0.8%, Up 0.5% Excluding Motor Vehicles
MT newswire•2026/09/15 18:57
Middleby Shares Rise After Upgrade From JPMorgan
MT newswire•2026/09/15 18:55
Cardiff Oncology Shares Rise After Upgrade From HC Wainwright
MT newswire•2026/09/15 18:55
Crypto prices
More
Bitcoin
BTC
$76,080.09
-3.76%
Ethereum
ETH
$2,402.86
-5.30%
Tether USDt
USDT
$0.9993
-0.05%
BNB
BNB
$717.1
-1.40%
XRP
XRP
$1.32
-9.51%
USDC
USDC
$0.9999
+0.01%
Solana
SOL
$98.16
-5.07%
TRON
TRX
$0.3324
-2.39%
Hyperliquid
HYPE
$77.07
-5.27%
Zcash
ZEC
$1,143.67
-4.03%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now